Humana Inc Etf Current Asset
| HUM Etf | USD 317.52 2.88 0.92% |
Humana Inc fundamentals help investors to digest information that contributes to Humana's financial success or failures. It also enables traders to predict the movement of Humana Etf. The fundamental analysis module provides a way to measure Humana's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Humana etf.
Humana |
Humana Inc ETF Current Asset Analysis
Humana's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Humana Current Asset | 2.76 B |
Most of Humana's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Humana Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
In accordance with the recently published financial statements, Humana Inc has a Current Asset of 2.76 B. This is much higher than that of the Health Care Providers & Services family and significantly higher than that of the Health Care category. The current asset for all United States etfs is notably lower than that of the firm.
Humana Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Humana's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of Humana could also be used in its relative valuation, which is a method of valuing Humana by comparing valuation metrics of similar companies.Humana is currently under evaluation in current asset as compared to similar ETFs.
Humana ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Humana's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Humana's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Humana Fundamentals
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.0634 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0 % | ||||
| Current Valuation | 29.3 B | ||||
| Shares Outstanding | 120.55 M | ||||
| Shares Owned By Insiders | 0.20 % | ||||
| Shares Owned By Institutions | 94.16 % | ||||
| Number Of Shares Shorted | 2.45 M | ||||
| Price To Earning | 19.12 X | ||||
| Price To Book | 2.32 X | ||||
| Price To Sales | 0.35 X | ||||
| Revenue | 106.44 B | ||||
| Gross Profit | 17.18 B | ||||
| EBITDA | 4.6 B | ||||
| Net Income | 2.49 B | ||||
| Cash And Equivalents | 5.06 B | ||||
| Cash Per Share | 143.73 X | ||||
| Total Debt | 12.27 B | ||||
| Debt To Equity | 0.85 % | ||||
| Current Ratio | 1.53 X | ||||
| Book Value Per Share | 133.05 X | ||||
| Cash Flow From Operations | 3.98 B | ||||
| Short Ratio | 1.62 X | ||||
| Earnings Per Share | 20.00 X | ||||
| Price To Earnings To Growth | 1.64 X | ||||
| Target Price | 381.28 | ||||
| Number Of Employees | 67.6 K | ||||
| Beta | 0.46 | ||||
| Market Capitalization | 38.28 B | ||||
| Total Asset | 46.89 B | ||||
| Retained Earnings | 27.54 B | ||||
| Working Capital | 366.27 M | ||||
| Current Asset | 2.76 B | ||||
| Current Liabilities | 2.39 B | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 0.64 % | ||||
| Net Asset | 46.89 B | ||||
| Last Dividend Paid | 3.54 |
About Humana Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Humana Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Humana using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Humana Inc based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Humana Piotroski F Score and Humana Altman Z Score analysis. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
The market value of Humana Inc is measured differently than its book value, which is the value of Humana that is recorded on the company's balance sheet. Investors also form their own opinion of Humana's value that differs from its market value or its book value, called intrinsic value, which is Humana's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Humana's market value can be influenced by many factors that don't directly affect Humana's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Humana's value and its price as these two are different measures arrived at by different means. Investors typically determine if Humana is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Humana's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.